Cardinal Health Products: Prescription Medications Section, Page 2

Page 2 of 99 « 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

AcipHex (Rabeprazole Sodium)

ACIPHEX is a proton-pump inhibitor (PPI) indicated in adults for: Healing of Erosive or Ulcerative Gastroesophageal Reflux Disease (GERD) (1.1) Maintenance of Healing of Erosive or Ulcerative GERD (1.2) Treatment of Symptomatic GERD (1.3) Healing of…

Cardinal Health11 November 2013

Actoplus Met (Pioglitazone Hydrochloride and Metformin Hydrochloride)

ACTOPLUS MET is a thiazolidinedione and biguanide combination product indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are already treated with a thiazolidinedione and metformin or…

Cardinal Health16 August 2012

Actos (Pioglitazone Hydrochloride)

ACTOS is a thiazolidinedione and an agonist for peroxisome proliferator-activated receptor (PPAR) gamma indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings…

Cardinal Health26 April 2013

Acyclovir

Acyclovir is indicated for the acute treatment of herpes zoster (shingles). Genital Herpes. Acyclovir is indicated for the treatment of initial episodes and the management of recurrent…

Cardinal Health22 April 2020

Adenocard (Adenosine)

Intravenous Adenocard (adenosine injection) is indicated for the following. Conversion to sinus rhythm of paroxysmal supraventricular tachycardia (PSVT), including that associated with accessory bypass tracts (Wolff-Parkinson-White Syndrome). When…

Cardinal Health19 January 2018

Page 2 of 99 « 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

FDA Medwatch

BD Announces FDA Classifications for August 4th Recalls of BD Alaris™ System Hardware for Keypads, Incorrect Module Types and/or Sizes, and Channel Error
Sun, 20 Sep 2020. Three of the recalls, which BD announced on Aug. 4, 2020, have been designated as Class I recalls by the U.S. Food and Drug Administration (FDA), which means that FDA has determined that there is a reasonable probability that the use of the product…
Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Two Lots of NP Thyroid®, Thyroid Tablets, USP Due to Sub Potency
Wed, 16 Sep 2020. Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level. The products are being recalled because testing has…

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.